Algae Medical Solutions – Part 9

Algae Therapeutics for Hypertension and Cancer

October 6, 2013
AlgaeIndustryMagazine.com

Both macro and microalgae contain many therapeutic compounds that provide medical benefit for hypertension, cancer and blood clotting. The medical literature is filled with laboratory tests for new algae species collected in common places or distant oceans that when tested for therapeutic value demonstrate significant benefit. Most algae species contain multiple compounds that offer medical solutions.

Medically active compounds harvested from algae

Medically active compounds harvested from algae

Hypertension

Hypertension or high blood pressure affects 1 in 3 Americans. Hypertension increases the force of the blood against artery walls and eventually causes health problems, such as heart disease, strokes, kidney damage, organ damage or heart failure. The CDC reported that in 2010, high blood pressure was projected to cost the United States $93.5 billion in health care services, medications and missed days of work.

High blood pressure is called the “silent killer” because it usually shows no warning signs. Many people do not know that they have high blood pressure because the diseases typically displays no symptoms, other than high blood pressure readings.

Blood pressure is determined by the amount of blood your heart pumps and the amount of resistance to blood flow in your arteries. The more blood your heart pumps and the narrower your arteries, the higher your blood pressure. High blood pressure occurs when readings average 140/90 or higher for either number. People with diabetes are treated if their blood pressure rises above 130/80, because they already have a high risk of heart disease.

Blood pressure

Blood pressure

Omega-3 supplements have been shown to lower total blood fat, which lowers blood pressure. DHA and EPA supplements can also cut elevated triglyceride levels. Triglycerides are blood fats that are a risk factor for heart disease.

Omega-3 fatty acids appear to lower the overall risk of death from heart disease. Omega-3 may reduce arrhythmias. Omega-3 slow the development of plaques in the arteries, probably because omega-3 moderate inflammation and maintain tissue pliability. Patients who take omega-3 supplements after a heart attack cut their risk of having another heart attack significantly. Eating fish once or twice a week or taking omega-3 supplements lowers the risk of stroke.

Ben-Gurion University researchers in Israel isolated a microalgal strain, which can accumulate up to 15% dry weight of a polyunsaturated fatty acid, PUFA called DGLA (Dihomo-γ-Linolenic Acid). Omega-3 and omega-6 PUFA have been shown to reduce blood pressure, chronic inflammation and blood cholesterol level, reducing the risk for heart attacks. Algae Biosciences has developed an algae mutant strain that produces over 30% dry weight of EPA oil. Some algae strains produce predominately DHA, EPA or DGLA, while others produce a mix of two or all the PUFAs.

Blood pressure and body fat

Blood pressure and body fat

Cancer

Cancer is a set of diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems. There are more than 100 different types of cancer and most cancers are named for the organ or type of cell in which they start. Cancer that begins in the colon is called colon cancer while cancer that begins in melanocytes of the skin is called melanoma.

The CDC reported a total of 1,660,000 new cancer cases and 580,000 deaths from cancer in the U.S. in 2011. Direct medical costs for cancer were about $125 billion in 2011. Death rates are slightly higher for men. Death rates in the U.S. continue to decrease but cancer death rates for the least educated segment of the population are 2 ½ times higher than for the most educated.

Medical tests on algae compounds have addressed at least 70 types of cancer. The most common therapeutic strategy is to find algae compounds such as astaxanthin and metabolites including zonaquinone acetate and flabellinone that create growth inhibitory effects on cancer cells. The natural algae compound fucoxanthin has strong antioxidant and cytotoxicity against breast, lung and prostate cancer. Algae sulfated polysaccharides have been shown to inhibit cell proliferation and to induce apoptosis by inhibiting IGF-IR signaling in several cancers. Other algae metabolites operate as antioxidants and protect against DNA damage.

Cancer tumor and skin cancer cells

Cancer tumor and skin cancer cells

Algae also produce steroids that have been shown to inhibit both cancer cells and cancerous tumors. Scientists are regularly discovering new bioactive steroids in algae species such as Sargassum that exhibit cytotoxic activity against various cancer cell lines.  

A promising new line of research focuses on cancer vaccination, to make cells immune from the onset of cancer. One of the most successful approaches has been working with genetically modified tumor cells that are introduced into a patient’s body. Algae toxins enable researchers to harvest natural toxins that strengthen the immune response in rodents.

Algae can be viewed as a potential antioxidant and anti-inflammatory sources, owing to their capability of producing compounds for cell protection from environmental factors such as heat, pollution, stress, oxygen concentration and UV radiation.

Anticoagulants

Anticoagulants are substances that prevent blood coagulation, (clotting). These substances occur naturally in leeches, blood-sucking insects and some algae species. Algae offer a broad array of novel sulfated polysaccharides with diverse chemical characteristics that produce a variety of natural anticoagulants useful for different medical conditions.

Anticoagulants are used to prevent the blood from forming dangerous clots that could result in a stroke or heart attack. These blood thinners are often the first medication prescribed by doctors following a stroke. By reducing the ability of the blood to clot — and thereby reducing the likelihood of coronary or vascular emboli—anticoagulants are frequently used in patients who are already at high-risk for stroke.

Marine algae are valuable sources of novel bioactive compounds with anticoagulant effect. Phlorotannins and sulfated polysaccharides such as fucoidans in brown algae, carrageenans in red algae, and ulvans in green algae have been recognized as potential anticoagulant agents.

Both freshwater and marine algae offer a large number of natural anticoagulant polysaccharides that have been isolated and characterized. Algae polysaccharides typically exert anticoagulant activity through antithrombin III and/or heparin cofactor II. These are important endogenous inhibitors, called SERPIN. The anticoagulant mechanism occurs when heparin, heparin sulfate and dermatan sulfate exert their activity. Some algae anticoagulant polysaccharides exert anticoagulant activity by directly inhibiting fibrin polymerization and/or thrombin activity.

New functions of algae anticoagulant polysaccharides have been discovered recently. Heparin and its derivatives derived from algae have important roles in many biological processes. Algae anticoagulant polysaccharides activate the fibrinolysis system and modulate endothelial cell functions. Biologically active compounds in algae have displayed anti-platelet and anticoagulant proteins and fibrinolytic enzymes. Algae polysaccharides and proteins have attracted the attention of biomedical scientists because they supply potent natural medical agents.

Today, most algae therapeutic compounds are harvested from natural algae stands in oceans or estuaries. Soon, algapreneurs will cultivate marine and freshwater algae with the strategy to harvest not one but a set of therapeutic compounds that address a broad spectrum of treatments. Each new algae therapeutic compound discovered in the laboratory offers a business opportunity for microfarmers.

More Like This…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
The Algae Biomass Organization (ABO) released the following statement calling on the EPA to include Carbon Capture and Utilization strategies in rules proposed June 2, 20...
Four years after the first optimistic calculations, the experimental cultivation of algae at Wageningen University in the Netherlands appears to be meeting expectations. ...
Kazuaki Nagata reports from Japan that while the Fukushima nuclear disaster has prompted vigorous discussion about alternative energy in Japan, there is a lack of a paral...
Algae Industry Magazine is pleased to announce a new Algae 101 series by our popular blogger, Mark Edwards, Professor, Arizona State University. The Algae Solutions to Na...
Kyae Mone Win reports in the Myanmar Times that spirulina has been harvested from Twin Daung lake in Sagaing’s Bu Ta Lin township for over a decade, but climate change an...
Starting in the early 70s, agencies in the former USSR invested more than 20,000 person-years of research and development to produce Bio-Algae Concentrates (BAC) that hel...
Algae manufacturer Cyanotech Corporation has announced implementing three major initiatives to improve Astaxanthin production at their Kailua Kona, Hawaii-based cultivati...
A recent discovery in the multicellular green alga, Volvox carteri,has revealed the origin of male and female sexes, showing how they evolved from a more primitive mating...
Perth, Western Australia-based Algae.Tec Limited has announced that the Reliance Group has converted the first tranche of options following the positive progress achieved...
In an effort to propel the algae industry forward, the Algae Testbed Public Private Partnership (ATP3) offers a series of hands-on specialized workshops suited for partic...
Following a request from the European Commission, the European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) was recently asked t...
Oregon State University researchers are combining diatoms, a type of single-celled photosynthetic algae, with nanoparticles to create a sensor capable of detecting minisc...
Chase Ezell writes in Earth911.com about the irony of Algenol’s biggest friction source on the way to marketing their carbon reducing algal-based ethanol being — the EPA ...
Portuguese cement facility, Secil, and microalgae biotechnology company, A4F, also based in Portugal, have formed AlgaFarm, a joint venture to develop the use of cement f...
U.S. farmers and biofuels makers are watching for the Environmental Protection Agency’s (EPA’s) final decision on the 2014 Renewable Fuel Standard rules, which will set t...
A team of Michigan State University algae researchers have discovered a cellular "snooze button" that has the potential to improve biofuel production and offer ...
Solazyme, Inc. and Versalis, the chemical subsidiary of Eni S.p.A., one of the world’s largest oil and gas companies, today announced a partnership to expand the commerci...
Hortidaily.com reports that in Nevele, Belgium, Tomalgae is growing algae in a former tomato greenhouse. Their company was formed when tomato cultivation entrepreneurs Pi...